Harpoon Therapeutics and AbbVie Announce Licensing and Option Collaboration to Advance HPN217, Harpoon’s BCMA-Targeting TriTAC®, and Expand Existing Discovery Collaboration

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Bud Bilanich
Success Coach

Amy Giles
Increasing Engagement

David Linetsky
Point-of-Care Marketing

Daniel Sontupe
Market Access

Pat Purcell
Meeting Engagement

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs